Catalog No.:AA0003M1

101080-03-9 | 1-chloro-4-methoxy-2-methyl-5-nitrobenzene

Name: Name:1-chloro-4-methoxy-2-methyl-5-nitrobenzene
Brand: AABLOCKS
SKU: AA0003M1
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

50mg

95%

3 weeks

$188.00 $132.00

- +

100mg

95%

3 weeks

$224.00 $157.00

- +

250mg

95%

3 weeks

$270.00 $189.00

- +

500mg

95%

3 weeks

$361.00 $253.00

- +

95%

3 weeks

$429.00 $300.00

- +

2.5g

95%

3 weeks

$740.00 $518.00

- +

95%

3 weeks

$1,256.00 $879.00

- +

10g

95%

3 weeks

$2,290.00 $1,603.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA0003M1

Chemical Name:

1-chloro-4-methoxy-2-methyl-5-nitrobenzene

CAS Number:

101080-03-9

Molecular Formula:

C8H8ClNO3

Molecular Weight:

201.6070

MDL Number:

MFCD01861454

SMILES:

COc1cc(C)c(cc1[N+](=O)[O-])Cl

Properties

Downstream Synthesis Route

101080-03-9

101581-13-9

[1]CurrentPatentAssignee:SENTINELONCOLOGY-WO2011/141716,2011,A2Locationinpatent:Page/Pagecolumn104

[2]CurrentPatentAssignee:ASTRAZENECAPLC-WO2008/40951,2008,A1Locationinpatent:Page/Pagecolumn172

[3]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2019/8011,2019,A1Locationinpatent:Page/Pagecolumn153

[4]Troschtschenko[ZhurnalObshcheiKhimii,1958,vol.28,p.2207,2211;engl.Ausg.S.2245,2248]

[5]CurrentPatentAssignee:ROCHEHOLDINGAG-US2012/15962,2012,A1Locationinpatent:Page/Pagecolumn63-64

[6]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2014/97140,2014,A1Locationinpatent:Page/Pagecolumn85

[7]CurrentPatentAssignee:CHARLESRIVERLABORATORIESINTERNATIONALINC;JOHNSON&JOHNSONINC-WO2017/125530,2017,A1Locationinpatent:Page/Pagecolumn289;290

7147-89-9

77-78-1

101080-03-9

[1]Basak,Anindita;Nayak,MrinalK.;Chakraborti,AsitK.[TetrahedronLetters,1998,vol.39,#27,p.4883-4886]

[2]CurrentPatentAssignee:MERCKKGAA-WO2005/82853,2005,A1Locationinpatent:Page/Pagecolumn217

101080-03-9

569688-67-1

[1]CurrentPatentAssignee:MERCKKGAA-WO2005/85220,2005,A1Locationinpatent:Page/Pagecolumn70-71

[2]CurrentPatentAssignee:ROCHEHOLDINGAG-WO2017/37146,2017,A1Locationinpatent:Page/Pagecolumn157;158;175

[3]CurrentPatentAssignee:MONTEROSATHERAPEUTICSAG-WO2021/69705,2021,A1Locationinpatent:Page/Pagecolumn155-156

[4]Li,Gaoquan;Hasvold,LisaA.;Tao,Zhi-Fu;Wang,GaryT.;GwaltneyII,StephenL.;Patel,Jyoti;Kovar,Peter;Credo,RobertB.;Chen,Zehan;Zhang,Haiying;Park,Chang;Sham,HingL.;Sowin,Thomas;Rosenberg,SaulH.;Lin,Nan-Horng[BioorganicandMedicinalChemistryLetters,2006,vol.16,#8,p.2293-2298]

[5]CurrentPatentAssignee:MONTEROSATHERAPEUTICSAG-WO2022/152822,2022,A1Locationinpatent:Page/Pagecolumn181;214

[6]CurrentPatentAssignee:MONTEROSATHERAPEUTICSAG-WO2022/152822,2022,A1Locationinpatent:Page/Pagecolumn181;214

7147-89-9

74-88-4

101080-03-9

[1]CurrentPatentAssignee:SENTINELONCOLOGY-WO2011/141716,2011,A2Locationinpatent:Page/Pagecolumn103-104

[2]CurrentPatentAssignee:CHARLESRIVERLABORATORIESINTERNATIONALINC;JOHNSON&JOHNSONINC-WO2017/125530,2017,A1Locationinpatent:Page/Pagecolumn289

[3]CurrentPatentAssignee:JOHNSON&JOHNSONINC-WO2019/8011,2019,A1Locationinpatent:Page/Pagecolumn151

[5]CurrentPatentAssignee:IDORSIAPHARMACEUTICALSLTD-WO2014/97140,2014,A1Locationinpatent:Page/Pagecolumn85

[6]CurrentPatentAssignee:MONTEROSATHERAPEUTICSAG-WO2022/152822,2022,A1Locationinpatent:Page/Pagecolumn181;214

[7]CurrentPatentAssignee:MONTEROSATHERAPEUTICSAG-WO2022/152822,2022,A1Locationinpatent:Page/Pagecolumn181;214

101080-03-9

886981-68-6

[1]Li,Gaoquan;Hasvold,LisaA.;Tao,Zhi-Fu;Wang,GaryT.;GwaltneyII,StephenL.;Patel,Jyoti;Kovar,Peter;Credo,RobertB.;Chen,Zehan;Zhang,Haiying;Park,Chang;Sham,HingL.;Sowin,Thomas;Rosenberg,SaulH.;Lin,Nan-Horng[BioorganicandMedicinalChemistryLetters,2006,vol.16,#8,p.2293-2298]

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS